Department of Gastroenterology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School; The First people's Hospital of Yancheng, Yancheng, Jiangsu, China.
Department of Pathology, Shanghai Public Health Clinical Center, Shanghai, China.
Saudi J Gastroenterol. 2022 Mar-Apr;28(2):92-100. doi: 10.4103/sjg.sjg_260_21.
Nonalcoholic fatty liver disease (NAFLD) has become one of the leading etiologies of hepatocellular carcinoma (HCC), but risk factors for NAFLD-related HCC occurrence have not been defined. NAFLD is often complicated by metabolic abnormalities, and there is a bidirectional association of metabolic abnormalities with NAFLD progression. This study aimed to systematically evaluate the relationship between metabolic traits and HCC occurrence in patients with NAFLD.
This study reviewed eight eligible studies that included 297,956 participants, to determine the relationship between metabolic traits and the occurrence of HCC in patients with NAFLD.
Presence of diabetes mellitus (DM) was associated with increased risk of HCC (HR: 2.65, 95%CI: 2.02 ~ 3.49, P = 0.589, I = 0.0%). Stratified analysis revealed that this risk was higher in NAFLD patients with advanced fibrosis/cirrhosis (HR: 4.55, 95%CI: 2.34 ~ 8.87, P = 0.870, I = 0.0%). Nonetheless even in patients without cirrhosis, DM remained a high risk factor for HCC incidence (HR: 1.80, 95%CI: 1.05 ~ 3.06, P = 0.291, I = 10.4%). Overweight/obesity had a slight correlation with increased risk of HCC occurrence in NAFLD patients (HR: 1.31, 95%CI: 1.00 ~ 1.71, P = 0.888, I = 0.0%), while presence of hypertension and dyslipidemia had no correlation.
DM and overweight/obesity are high risk factors for NAFLD-related HCC. In particular, DM increases 4-fold the risk of HCC incidence in NAFLD patients with advanced fibrosis/cirrhosis. There is a need to strengthen surveillance for HCC in NAFLD patients with DM, especially in those with advanced fibrosis/cirrhosis.
非酒精性脂肪性肝病(NAFLD)已成为肝细胞癌(HCC)的主要病因之一,但 NAFLD 相关 HCC 发生的危险因素尚未确定。NAFLD 常伴有代谢异常,代谢异常与 NAFLD 进展之间存在双向关联。本研究旨在系统评估代谢特征与 NAFLD 患者 HCC 发生的关系。
本研究综述了 8 项纳入 297956 名参与者的研究,以确定代谢特征与 NAFLD 患者 HCC 发生之间的关系。
糖尿病(DM)的存在与 HCC 风险增加相关(HR:2.65,95%CI:2.023.49,P=0.589,I=0.0%)。分层分析显示,在伴有晚期纤维化/肝硬化的 NAFLD 患者中,这种风险更高(HR:4.55,95%CI:2.348.87,P=0.870,I=0.0%)。尽管在没有肝硬化的患者中,DM 仍然是 HCC 发生的高危因素(HR:1.80,95%CI:1.053.06,P=0.291,I=10.4%)。超重/肥胖与 NAFLD 患者 HCC 发生风险略有增加相关(HR:1.31,95%CI:1.001.71,P=0.888,I=0.0%),而高血压和血脂异常与 HCC 发生无相关性。
DM 和超重/肥胖是 NAFLD 相关 HCC 的高危因素。特别是在伴有晚期纤维化/肝硬化的 NAFLD 患者中,DM 使 HCC 发病率增加了 4 倍。需要加强对 DM 合并 NAFLD 患者的 HCC 监测,尤其是在伴有晚期纤维化/肝硬化的患者中。